Literature DB >> 8102509

Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.

N Moghrabi1, D J Clarke, B Burchell, M Boxer.   

Abstract

Crigler-Najjar syndrome type 1 (CN-1) is a familial disorder characterized by severe unconjugated hyperbilirubinemia and jaundice and leads to kernicterus, neurological damage, and eventual death unless treated with liver transplantation. Previous reports identified mutations in the UGT1 gene complex to be the cause of the disease. The total absence of all phenol/bilirubin UGT proteins and their activities in liver homogenate of a CN-1 patient was determined by enzymological and immunochemical analysis. A novel homozygous nonsense mutation (CGA-->TGA) was identified in the patient by the combined techniques of PCR and direct sequencing. This mutation was located in exon 3 of the constant region in the gene complex which is common to all phenol and bilirubin UGTs. The segregation of the mutation in the patient's family was analyzed and confirmed the recessive nature of the disease. Newly developed intragenic polymorphic probes (UGT1* 4 and UGT-Const) were used on Southern blots of MspI-digested genomic DNA of the patient and his family. The segregation of individual alleles within the family was observed from haplotypes generated. Comparison of the segregation of haplotypes with the mutation for the patient and his family revealed the allele identified by the A1-B1-C2 haplotype to be carrying the mutation. The risk of recombination occurring is negligible, because of the intragenic nature of the probes. This study demonstrates the potential usefulness of these probes in carrier detection and prenatal/presymptomatic diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102509      PMCID: PMC1682423     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  A frameshift mutation in a patient with Tay-Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of beta-hexosaminidase.

Authors:  M M Lau; E F Neufeld
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 3.  UDP-glucuronosyltransferases.

Authors:  B Burchell; M W Coughtrie
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

4.  Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells.

Authors:  D Harding; S Fournel-Gigleux; M R Jackson; B Burchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Nonsense mutations in the human beta-globin gene affect mRNA metabolism.

Authors:  S J Baserga; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol.

Authors:  P J Simons; I D Cockshott; E J Douglas; E A Gordon; K Hopkins; M Rowland
Journal:  Xenobiotica       Date:  1988-04       Impact factor: 1.908

7.  Nonsense mutations in the dihydrofolate reductase gene affect RNA processing.

Authors:  G Urlaub; P J Mitchell; C J Ciudad; L A Chasin
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Premature translation termination mediates triosephosphate isomerase mRNA degradation.

Authors:  I O Daar; L E Maquat
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Mutagenic deamination of cytosine residues in DNA.

Authors:  B K Duncan; J H Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

View more
  3 in total

Review 1.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

2.  Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.

Authors:  S Gantla; C T Bakker; B Deocharan; N R Thummala; J Zweiner; M Sinaasappel; J Roy Chowdhury; P J Bosma; N Roy Chowdhury
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

3.  Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.

Authors:  P Labrune; A Myara; M Hadchouel; F Ronchi; O Bernard; F Trivin; N R Chowdhury; J R Chowdhury; A Munnich; M Odièvre
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.